Fibrodyplasia Ossificans Progressiva (FOP)
1 clinical trials · Condition
◉ Watch Fibrodyplasia Ossificans Progressiva (FOP)
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP) (NCT04577820) | Regeneron Pharmaceuticals | 2021-10-13 |
Track Fibrodyplasia Ossificans Progressiva (FOP) automatically
Every clearance here is in the API, with alerts when new ones post.